Skip to main content

GSA CAPITAL PARTNERS LLP

Position in MGNX — Macrogenics Inc

CIK 1362033 LONDON, X0

Position in MGNX

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$1,097,179
+$274,463 QoQ
Shares Held
379,647
-25.7% QoQ
Ownership
0.596%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in MGNX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,097,179 379,647
2025-12-31 $822,716 511,004
2025-09-30 $102,145 60,801
2025-03-31 $569,633 448,530
2024-12-31 $801,463 246,604
2024-09-30 $683,915 207,877
2024-06-30 $406,678 95,689
2023-12-31 $1,190,147 123,716
2023-09-30 $1,052,777 225,918
2023-06-30 $690,995 129,158
2023-03-31 $283,609 39,555
2022-12-31 $386,522 57,604
2022-06-30 $39,282 13,316
2021-12-31 $367,496 22,897
2020-03-31 $320,216 55,020